Get the detailed quarterly/annual income statement for Blueprint Medicines Corporation (BPMC). Find out the revenue, expenses and profit or loss over the last fiscal year.
Dec 09, 2021 · The largest stake in Blueprint Medicines Corporation (NASDAQ:BPMC) was held by Casdin Capital, which reported holding $159.4 million worth of stock at the end of September.It was followed by ...
Find the latest Blueprint Medicines Corporation (BPMC) stock quote, history, news and ... Investment company SFT Delaware Ivy Small Cap Growth Fund (Current ...
Blueprint Medicines' (BPMC) Ayvakit Aids Growth Amid Rivalry. Blueprint Medicines' (BPMC) Ayvakit, which has been approved to treat PDGFRA Exon 18 mutant gastrointestinal stromal tumors, has seen ...
Find the latest Blueprint Medicines Corporation (BPMC) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Find the latest Blueprint Medicines Corporation (BPMC) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Find the latest Blueprint Medicines Corporation (BPMC) stock quote, history, news and other vital information to help you with your stock trading and investing.
Find the latest Blueprint Medicines Corporation (BPMC) stock quote, history, news and other vital information to help you with your stock trading and investing.
31.12.2021 · Shares of Blueprint Medicines Corporation BPMC have rallied 24.8% in the past six months against the industry’s decrease of 18.7%. Image Source: Zacks Investment Research The company has made ...
Dec 31, 2021 · Shares of Blueprint Medicines Corporation BPMC have rallied 24.8% in the past six months against the industry’s decrease of 18.7%. Image Source: Zacks Investment Research The company has made ...
Blueprint Medicines' (BPMC) Ayvakit Aids Growth Amid Rivalry. Blueprint Medicines' (BPMC) Ayvakit, which has been approved to treat PDGFRA Exon 18 mutant gastrointestinal stromal tumors, has seen ...